Atopic keratoconjunctivitis

References

• Coca A F, Cooke R A. On the classification of the phenomena of hypersensitivities. J Immunol 1923; 8: 163–182
   Google Scholar
• Carr R D, Berke M, Becker S W. Incidence of atopy in the general population. Arch Dermatol 1964; 89: 27–32
   PubMedGoogle Scholar
• Braude L S, Chandler J W. Atopic corneal disease. Int Ophthalmol Clin 1984; 24(2)145–156
   PubMedGoogle Scholar
• Buckley R. Atopic disease of the cornea. The Cornea: Transactions of the World Congress of the Cornea III, H D Cavanagh. Raven Press, New York 1988; 435–437
   Google Scholar
• Allansmith M R, Abelson M B. Ocular allergies. The Cornea. Scientific Foundations and Clinical Practice, G Smolin, R A Thoft. Little Brown, Boston 1983; 241–243
   Google Scholar
• Dart J KG, Buckley R J, Monnickendan M, Prasad J. Perennial allergic conjunctivitis: definition, clinical characteristics and prevalence. A comparison with seasonal allergic conjunctivitis. Trans Ophthalmol Soc UK 1986; 105: 513–520
   PubMedGoogle Scholar
• Ehlers W H, Donshik P C. Allergic ocular disorders: A spectrum ofdiseases. CLAO 1992; 18: 117–124
   PubMedGoogle Scholar
• Allansmith M R, Korb D R, Greiner J V, Henriquez A S, Simon M A. Finnemore VM. Giant papillary conjunctivitis in contact lens wearers. Am J Ophthalmol 1977; 83: 697–708
   PubMed Web of Science ®Google Scholar
• Allansmith M R, Baird R S, Greiner J V. Vernal conjunctivitis and contact lens-associated giant papillary conjunctivitis compared and contrasted. Am J Ophthalmol 1979; 87: 544–555
   PubMed Web of Science ®Google Scholar
• Tuft S J, Dart J KG, Kemeny M. Limbal vernal keratoconjunctivitis: clinical characteristics and immunoglobulin E expression compared to palpebral vernal. Eye 1989; 3: 420–427
   PubMed Web of Science ®Google Scholar
• Jones B R. Vernal keratitis. Trans Ophthalmol Soc UK 1961; 81: 215–228
   Google Scholar
• Rich F L, Hanifin J M. Ocular complications of atopic dermatitis and other eczemas. Int Ophthalmol Clin 1985; 26: 61–76
   Google Scholar
• Brunsting L A, Reed W B, Bair H L. Occurrence of cataracts and keratoconus with atopic dermatitis. Arch Dermatol 1955; 72: 237–241
   Web of Science ®Google Scholar
• Hogan M J. Atopic keratoconjunctivitis. Trans Am Ophthalmol Soc 1952; 50: 265–281
   PubMedGoogle Scholar
• Hogan M J. Atopic keratoconjunctivitis. Am J Ophthalmol 1953; 36: 937–947
   PubMedGoogle Scholar
• Karel I, Myska V, Kvicalova E. Ophthalmological changes in atopic dermatitis. Acta Dermatol Venereol 1965; 45: 381–386
   PubMedGoogle Scholar
• Garrity J A, Liesegang T J. Ocular complications of atopic dermatitis. Can J Ophthalmol 1984; 9: 21–24
   Google Scholar
• Tuft S J, Kemeny M, Dart J KG, Buckley R J. Clinical features of atopic keratoconjunctivitis. Ophthalmology 1991; 98: 150–158
   PubMed Web of Science ®Google Scholar
• Foster C S, Calonge M. Atopic keratoconjunctivitis. Ophthalmology 1990; 97: 992–1000
   PubMed Web of Science ®Google Scholar
• Friedlaender M H. Conjunctivitis of allergic origin: clinical presentation and differential diagnosis. Surv Ophthalmol 1993; 38(Suppl)105–114
   PubMedGoogle Scholar
• Ishizaka K. Regulation of immunoglobulin E biosynthesis. Adv Immunol 1989; 47: 1–44
   PubMedGoogle Scholar
• Blumenthal M, Marcus-Bagley D, Awdeh Z, Johnson B, Yunis E J, Alper C A. HLA-DR2 [HLA-B7, SC31, DR2] and [HLA-B8, SC01, DR3] haplotypes distinguish subjects with asthma from those with rhinitis only in ragweed pollen allergy. J Immunol 1992; 148: 411–416
   PubMedGoogle Scholar
• Marsh D G, Hsu S H, Roebber M., Ehrlich-Kautzky E, Freidhoff L R, Meyers D A, et al. HLA-Dw2: a genetic marker for human immune response to shart ragweed pollen allergen Ra5. I. Response resulting primarily from natural antigenic exposure. J Exp Med 1982; 155: 1439–1451
   PubMedGoogle Scholar
• Oshinskie L, Haine C. Atopic dermatitis and its complications. J Am Optom Assoc 1982; 53: 889–894
   PubMedGoogle Scholar
• Jay J L. Clinical features and diagnosis of adult atopic keratoconjunctivitis and the effect of treatment with sodium cromoglycate. Br J Ophthalmol 1981; 65: 335–340
   PubMedGoogle Scholar
• Rao M, Victoria M S, Jabbar H, Steiner P. Atopic dermatitis, asthma, and eye changes in children. J Asthma 1981; 18: 47–48
   PubMed Web of Science ®Google Scholar
• Plaut M, Pierce J H, Watson C J, Hanley-Hyde J, Nordan R P, Paul W E. Mast cell lines produce lymphokines in response to crosslinkage of Fce RI or to calcium ionophores. Nature 1989; 339: 64–67
   PubMed Web of Science ®Google Scholar
• Abelson B M, Schaefer K. Conjunctivitis of allergic origin: immunologic mechanisms and current approaches to therapy. Surv Ophthalmol 1993; 38(Suppl)115–132
   PubMed Web of Science ®Google Scholar
• Stevens R L. Austen KF. Recent advances in the cellular and molecular biology of mast cells. Immunol Today 1989; 10: 381–386
   PubMedGoogle Scholar
• Romagnani S. Regulation and deregulation of human IgE synthesis. Immunol Today 1990; 11: 316–321
   PubMedGoogle Scholar
• Carapeto F J, Winkelmann R K, Jordon R E. T and B lymphocytes in contact and atopic dermatitis. Arch Dermatol 1976; 112: 1095–1100
   PubMedGoogle Scholar
• Geha R S, Reinherz E, Leung D, McKee K T, Jr, Schlossman S, Rosen F S. Deficiency of suppressor T cells in the hyperimmunoglobulinemia E syndrome. J Clin Invest 1981; 68: 783–791
   PubMedGoogle Scholar
• McGeady S J, Buckley R H. Depression of cell-mediated immunity in atopic eczema. J Allergy Clin Immunol 1975; 56: 393–406
   PubMedGoogle Scholar
• Nelson H S. The atopic diseases. Ann Allergy 1985; 55: 441–447
   PubMedGoogle Scholar
• Bacon A S, Tuft S J, Metz D M, McGill J I, Buckley R J, Baddeley S, Lightman S L. The origin of keratopathy in chronic allergic eye disease: a histopathological study. Eye 1993; 21–25, (Suppl)
   PubMedGoogle Scholar
• Udell I J, Gleich G J, Allansmith M R, Ackerman S J, Abelson M B. Eosinophil major basic protein and Charcot-Leyden crystal protein in human tears. Am J Ophthalmol 1981; 92: 824–828
   PubMed Web of Science ®Google Scholar
• Abelson M B, Baird R S, Allansmith M R. Tear histamine levels in vernal conjunctivitis and ocular inflammations. Ophthalmology 1980; 87: 812–814
   PubMed Web of Science ®Google Scholar
• Bonini S T, Bonini S E, Todini V, Adriani E, Allansmith M R. Late phase ocular reaction induced by conjunctival allergen challenge. A dose-response study in humans. J Allergy Clin Immunol 1988; 81: 173
   Google Scholar
• Akova Y A, Jabbur N, Neumann R, Foster C S. Atypical ocular atopy. Ophthalmology 1993; 100: 1367–1371
   PubMedGoogle Scholar
• Friedlaender M H. Foreword: diagnosing and managing allergic conjunctivitis. Surv Ophthalmol 1993; 38(Suppl)89–104
   Google Scholar
• Lammintausta K, Kalimo K, Fagerlund V L. Patch test reactions in atopic patients. Contact Dermatitis 1992; 26: 234–240
   PubMedGoogle Scholar
• Roitt I, Brostoff J, Male D. Radioimmunosorbent assay. Immunology, 3rd edn. CV Mosby, London 1993; 25–7
   Google Scholar
• Tuft S J, Dart J KG. The measurement of IgE in tear fluid: a comparison of collection by sponge or capillary. Acta Ophthalmol 1989; 67: 301–305
   Web of Science ®Google Scholar
• Butrus S I, Abelson M B. Laboratory evaluation of ocular allergy. Int Ophthalmol Clin 1988; 28: 324–328
   PubMedGoogle Scholar
• Shaff R E, Beaven M A. Increased sensitivity of the enzymatic isotopic assay of histamine: measurement of histamine in plasma and serum level. Anal Biochem 1979; 94: 425–430
   PubMed Web of Science ®Google Scholar
• Wenzel S, Irani A A, Sander J M, Bradford T R, Schwartz L B. The level of tryptase from human mast cells. J Immunol Methods 1986; 86: 139–142
   PubMed Web of Science ®Google Scholar
• Maskin S L, Heitman K F, Lawton A W, Yee R W. Diagnostic impression cytology for external eye disease. Cornea 1989; 8: 270–273
   PubMedGoogle Scholar
• Kimura S J, Thygeson P. The cytology of external ocular disease. Am J Ophthalmol 1955; 39: 137–144
   PubMed Web of Science ®Google Scholar
• Abelson M B, Madimale N, Weston J H. Conjunctival eosinophils in allergic eye disease. Arch Ophthalmol 1984; 102: 1198–1199
   PubMedGoogle Scholar
• Foster C S, Rice B A, Dutt J E. Immunopathology of atopic keratoconjunctivitis. Ophthalmology 1991; 98: 1190–1196
   PubMed Web of Science ®Google Scholar
• Morgan S J, Williams J H, Walls A F, Holgate S T. Mastcell hyperplasia in atopic keratoconjunctivitis. Eye 1991; 5: 729–735
   PubMedGoogle Scholar
• Morgan S J, Williams J H, Walls A F, Church M K, Holgate S T, McGill J I. Mast cell numbers and staining characteristics in the normal and allergic human conjunctiva. J Allergy Clin Immunol 1991; 87: 111–116
   PubMed Web of Science ®Google Scholar
• Roth H I, Kierland R R. The natural history of atopic dermatitis: a 20-year follow-up study. Arch Dermatol 1964; 89: 209–214
   PubMedGoogle Scholar
• Easty D L. External ocular diseases in atopic patients. External Eye Diseases, D L Easty, G Smolin. Butterworths, London 1985; 239–271
   Google Scholar
• Easty D L, Entwistle C, Fund A, Witcher J. Herpes simplex keratitis and keratoconus in the atopic patient. A clinical and immunological study. Trans Ophthalmol Soc UK 1975; 95: 267–276
   PubMedGoogle Scholar
• Tuft S J, Ramakrishnan M, Seal D V, Kemeny M, Buckley R J. Role of Staphylococcus aureus in chronic allergic conjunctivitis. Ophthalmology 1992; 99: 180–184
   PubMedGoogle Scholar
• Hanifin J M, Rogge J L. Staphylococcal infections in patients with atopic dermatitis. Arch Dermatol 1977; 113: 1383–1386
   PubMedGoogle Scholar
• Bibel D J, Greenberg J H, Cook J L. Staphylococcus aureus and the microbial ecology of atopic dermatitis. Can J Microbiol 1977; 23: 1062–1068
   PubMed Web of Science ®Google Scholar
• Anderson E K, Heilesen B. On the occurrence and typing of Staphylococcus pyogenes in weeping eczema (and the role played by these bacteria in the pathogenesis and course of eczema). Acta Dermatol 1951; 31: 679–703
   Google Scholar
• Aly R, Maibach H I, Shinefield H R. Microbial flora of atopic dermatitis. Arch Dermatol 1955; 72: 237–241
   Google Scholar
• Buckley R H, Wray B B, Belmaker E Z. Extreme hyperimmunoglobu-linemia E and undue susceptibility to infection. Pediatrics 1972; 49: 59–70
   PubMed Web of Science ®Google Scholar
• Butrus S I, Leung D YM, Gellis S, Baum J, Kenyon K R, Abelson M B. Vernal conjunctivitis in the hyperimmunoglobulinemia syndrome. Ophthalmology 1984; 91: 1213–1216
   PubMedGoogle Scholar
• Hill H R, Quie P G. Raised serum IgE levels and defective neutrophil chemotaxis in three children with eczema and recurrent bacterial infections. Lancet 1974; 1: 183–187
   PubMed Web of Science ®Google Scholar
• Aswad M I, Tauber J, Baum J. Plasmapheresis treatment in patients with atopic keratoconjunctivitis. Ophthalmology 1988; 95: 444–447
   PubMed Web of Science ®Google Scholar
• Copeman P WM. Eczema and keratoconus. Br J Med 1985; 2: 977–979
   Google Scholar
• Harrison R J, Klouda P T, Easty D L, Manku M, Steward J CCM. Association between keratoconus and atopy. Br J Ophthalmol 1989; 73: 816–822
   PubMed Web of Science ®Google Scholar
• Rahi A HS, Davies P D, Ruben M, Lobascher D, Menon J. Keratoconus and co-existing atopic disease. Br J Ophthalmol 1977; 61: 761–764
   PubMed Web of Science ®Google Scholar
• Kerr Muir M G, Woodward E G, Leonard T JK. Corneal thickness, astigmatism, and atopy. Br J Ophthalmol 1987; 71: 207–211
   PubMed Web of Science ®Google Scholar
• Beetham W. Atopic cataracts. Arch Ophthalmol 1940; 24: 21–37
   Google Scholar
• Amemiya T, Matsuda H, Uehara M. Ocular findings in atopic dermatitis with special reference to the clinical features of atopic cataract. Ophthalmologica 1980; 180: 129–132
   PubMed Web of Science ®Google Scholar
• Coles R S, Laval J. Retinal detachments occurring in cataract associated with neurodermatitis. Arch Ophthalmol 1952; 48: 30–39
   Google Scholar
• Hurlbut W B, Domonkos A N. Cataract and retinal detachment associated with atopic dermatitis. Arch Ophthalmol 1954; 52: 852–857
   Google Scholar
• Ingram R M. Retinal detachment associated with atopic dermatitis and cataract. Br J Ophthalmol 1965; 49: 96–97
   PubMed Web of Science ®Google Scholar
• Foster C S. Cicatricial pemphigoid. Thesis. Trans Am Ophthalmol Soc 1986; 84: 527–663
   PubMedGoogle Scholar
• Allansmith M R, Ross R N. Ocular allergy and mast cell stabilizers. Surv Ophthalmol 1986; 30: 229–244
   PubMed Web of Science ®Google Scholar
• Wiens J J, Jackson W B. New directions in therapy for ocular allergy. Int Ophthalmol Clin 1988; 28: 332–337
   PubMedGoogle Scholar
• Kulkarni P S, Srinivasan B D, Kaufman P. Comparison of cyclooxygenase and lipooxygenase pathways in rabbit and monkey ocular tis. Invest Ophthalmol Vis Sci 1985; 26(Suppl)191
   Google Scholar
• Gonzalez J P, Brogden R N. Nedocromil sodium: a preliminary review of its pharmacokinetic properties, and therapeutic efficacy in the treatment of reversible obstructive airway disease. Drugs 1987; 34: 560–577
   PubMed Web of Science ®Google Scholar
• Caldwell D R, Verin P, Hartwich-Young R, Meyer S M, Drake M M. Efficacy and safety of lodoxamide 0.1% vs cromolyn sodium 4% in patients with vernal keratoconjunctivitis. Am J Ophthalmol 1992; 113: 632–637
   PubMed Web of Science ®Google Scholar
• Foster C S. The cromolyn sodium collaborative study group. Evaluation of topical cromolyn sodium in the treatment of vernal keratoconjunctivitis. Ophthalmology 1988; 96: 194–201
   Google Scholar
• Abelson M B, Weston J H. Antihistamines. Clinical Ophthalmic Pharmacology, D W Lamberts, D E Potter. Little Brown, Boston 1987; 417–424
   Google Scholar
• Pipkorn U, Bende M, Hender J, Hender T. A double-blind evaluation of topical levocabastine, a new specific Hi antagonist in patients with allergic conjunctivitis. Allergy 1985; 40: 491–496
   PubMed Web of Science ®Google Scholar
• Flach A. Cyclo-oxygenase inhibitors in ophthalmology. Surv Ophthalmol 1992; 36: 256–284
   Google Scholar
• Bisgaard H, Ford-Hutchinson A W, Charleson S, Tauderf E. Production of leukotrienes in human skin and conjunctival mucosa after specific allergen challenge. Allergy 1985; 40: 417–423
   PubMed Web of Science ®Google Scholar
• Bhattacherjee P. The role of arachidonate metabolism in ocular inflammation. Prog Clin Biol Res 1989; 312: 211–214
   PubMedGoogle Scholar
• Rooks W H. Pharmacologic activity of ketocoralac tromethamine. Pharmacotherapy 1990; 10: 308–311
   PubMedGoogle Scholar
• Ballas Z, Blumenthal M, Tinkelman D G, Kriz R, Rupp G. Clinical evaluation of ketocorolac tromethamine 0.5% ophthalmic solution for treatment of seasonal allergic conjunctivitis. Surv Ophthalmol 1993; 38(Suppl)141–148
   PubMed Web of Science ®Google Scholar
• Tinkelman D, Rupp G, Kaufman H, Pugely J, Schultz N. Double-masked, paired-comparison clinical study of ketocoralac tromethamine 0.5% ophthalmic solution compared with placebo eyedrops in the treatment of seasonal allergic conjunctivitis. Surv Ophthalmol 1993; 38(Suppl)133–140
   PubMedGoogle Scholar
• Bishop K, Abelson M B, Cheetham J, Harper D. Evaluation of flurbiprofen in the treatment of antigen-induced allergic conjunctivitis. Invest Ophthalmol Vis Sci 1990; 31: 487–488
   Google Scholar
• Buckley D C, Caldwell D R, Reaves T A. Treatment of vernal conjunctivitis with suprofen, a topical nonsteroidal anti-inflammatory agent. Invest Ophthalmol Vis Sci 1986; 27: 29–37
   PubMedGoogle Scholar
• Chiou L Y, Chiou G CY. Ocular anti-inflammmatory action of a lipoxygenase inhibitor in the rabbit. J Ocul Pharmacol 1985; 1: 383–390
   PubMedGoogle Scholar
• Ford-Hutchinson A W. Lipoxygenase inhibitors as future anti-allergy drugs?. Proceedings: New Approaches to the Treatment of Allergic Diseases: An update on anti-allergy drugs. Int Business Co, Boston 1989; 43
   Google Scholar
• Jaanus S D. Anti-inflammatory Drugs. Clinical Ocular Pharmacology, J D Bartlett, S D Jaanus. Butterworths, Boston 1984; 161
   Google Scholar
• Leibowitz H M, Kupferman A. Anti-inflammatory medications. Int Ophthalmol Clin 1980; 20: 117–134
   PubMedGoogle Scholar
• Foster C S. Hypersensitivity reactions. Principles and Practice of Ophthalmology: Basic Science, D A Albert, F A Jakobiec. WB Saunders, Philadelphia 1993; 806–807
   Google Scholar
• Nussenblatt R B, Palestine A G. Cyclosporine: immunology, pharmacology and therapeutic uses. Surv Ophthalmol 1986; 31: 159–169
   PubMed Web of Science ®Google Scholar
• Cooper K D, Baadsgaard O, Ellis C N, Duell E, Voorhees J J. Mechanisms of cyclosporine A inhibition of antigenpresenting activity in uninvolved and lesional psoriatic epidermis. J Invest Dermatol 1990; 94: 649–656
   PubMed Web of Science ®Google Scholar
• Taylor R S, Baadsgaard O, Headington J T, Ellis C N, Voorhees J J, Cooper K D. Epidermal activation of autoreactive T cells in atopic dermatitis: response to cyclosporine A. J Invest Dermatol 1988; 90(Suppl)612
   Google Scholar
• VanJoost T, Kozel M MA, Tank B, Troost R, Prens E P. Cyclosporine in atopic dermatitis. Modulation in the expression of immunoglobulin markers in lesional skin. J Am Acad Dermatol 1992; 27: 922–928
   PubMedGoogle Scholar
• Sowden J M., Berth-Jones J, Ross J S, Motley R J, Marks R, Finlay A Y, et al. Double blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis. Lancet 1991; 338: 137–140
   PubMed Web of Science ®Google Scholar
• Ben Ezra D, Peter J, Brosky M, Cohen E. Cyclosporine eye drops for the treatment of severe vernal keratoconjunctivitis. Am J Ophthalmol 1986; 101: 278–282
   PubMed Web of Science ®Google Scholar
• Bleik J H, Tabbara K F. Topical cyclosporine in vernal keratoconjunctivitis. Ophthalmology 1991; 98: 1679–1684
   PubMed Web of Science ®Google Scholar
• Cohen G A, O'Connor R D, Hamburger R N. Safety and efficacy of human IgE pentapeptide. Ann Allergy 1985; 52: 83–96
   Google Scholar
• Bennich H, Ragnarsson U, Johansson S G, Ishizaka K, Ishizaka T, Levy D A, Lichtenstein L M. Future of the putative IgE pentapeptide to compete with IgE for receptors on basophils and mast cells. Int Arch Allergy Appl Immunol 1977; 53: 459–468
   PubMedGoogle Scholar
• Floyd R, Kalpaxis J, Thayer T, Rangus K. Double-blind comparison of HEPP (IgE pentapeptide) 0.5% ophthalmic solution (H) and sodium cromolyn ophthalmic solution, USP 4% (O) in patients having allergic conjunctivitis. Invest Ophthalmol Vis Sci 1988; 29(Suppl)45
   Google Scholar
• Hanifin J M, Schneider L C, Leung D YM, Ellis C N, Jaffe H S, Izu A E, et al. Recombinant interferon gamma therapy for atopic dermatitis. J Am Acad Dermatol 1993; 28: 189–197
   PubMed Web of Science ®Google Scholar
• Boguniewicz M, Jaffe H S, Izu A, Sullivan M J, York D, Geha R S, Leung D Y. Recombinant gamma interferon in treatment of patients with atopic dermatitis and elevated IgE levels. Am J Med 1990; 88: 365–370
   PubMed Web of Science ®Google Scholar
• Leung D YM, Hirsh R L, Schneider L, Moody C, Takaoka R, Li S H, et al. Thymopentin therapy reduces the clinical severity of atopic dermatitis. J Allergy Clin Immunol 1990; 85: 927–933
   PubMed Web of Science ®Google Scholar
• Baer J C, Foster C S. Corneal laser photocoagulation for treatment of neovascularization. Efficacy of 557 nm yellow dye laser. Ophthalmology 1992; 99: 173–179
   PubMedGoogle Scholar
• Lyons C J, Dart J K, Aclimandos W A, Lightman S, Buckley R J. Sclerokeratitis after keratoplasty in atopy. Ophthalmology 1990; 97: 729–733
   PubMedGoogle Scholar
• Young S R, Lundergan M K, Olson R J. Late complications of combined radial and transverse keratotomy after penetrating keratoplasty associated with atopic keratoconjunctivitis. Refractive & Corneal Surg 1989; 5: 194–197
   PubMedGoogle Scholar